世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の多発性血管炎性肉芽腫症治療薬市場の現状、動向、COVID-19影響レポート2021年版


Global Granulomatosis with Polyangiitis Drug Market Status, Trends and COVID-19 Impact Report 2021

世界の多発性血管炎性肉芽腫症治療薬市場の現状、動向、COVID-19影響レポート2021年版 シングルユーザーライセンスレポート:2350ドル コーポレートユーザーライセンスレポート:4700ドル セクションの価格です... もっと見る

 

 

出版社 出版年月 電子版価格 言語
BisReport Consulting Co., Ltd.
BISレポートコンサルティング
2021年12月6日 US$2,350
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

世界の多発性血管炎性肉芽腫症治療薬市場の現状、動向、COVID-19影響レポート2021年版
シングルユーザーライセンスレポート:2350ドル
コーポレートユーザーライセンスレポート:4700ドル
セクションの価格です。以下の通り

過去数年間で、多発性血管炎薬との肉芽腫症市場は、COVID - 19の影響下で巨大な変化を経験し、多発性血管炎薬との肉芽腫症の世界市場規模は2016年に(2016市場規模XXXX)から2021年に(2021市場規模XXXX)万ドルに達し、2016年から2021年のCAGRはXXXです。現在のところ、世界のCOVID-19コロナウイルスCasesは2億人を超え、世界的な流行は基本的にコントロールされているため、世界銀行は2021年と2022年の世界経済成長率を推定しています。世界銀行の予測では、2021年の世界経済生産は4%拡大する一方、2022年は3.8%拡大する見込みです。多発性血管炎薬による肉芽腫症市場と世界経済環境の調査によると、多発性血管炎薬による肉芽腫症の世界市場規模は2026年に(2026年市場規模XXXX)万ドルに達し、2021年から2026年のCAGRは%と予測されます。

COVID-19の大流行により、世界銀行の統計によると、2020年の世界のGDPは約3.5%縮小しています。2021年に入り、多くの国で経済活動が回復し始め、パンデミックの制限に部分的に適応しています。ワクチンの研究開発が画期的に進展し、多くの政府も米国を中心に景気回復を促す様々な政策を打ち出しており、経済活動に強い追い風となりそうだが、持続的成長の見通しは国やセクターによって大きく異なる。世界経済は、COVID-19による大不況から回復しつつありますが、パンデミック前のトレンドを下回る状態が長期に続くと思われます。パンデミックは、10年にわたる世界的な債務蓄積の波に伴うリスクを悪化させた。また、今後10年間に予想される潜在成長率の鈍化を急進させる可能性が高い。

世界はCOVID-19の流行回復期に入りました。この複雑な経済環境の中で、我々は、多発性血管炎薬とグローバル肉芽腫症市場の現状、動向とCOVID - 19影響レポート2021を公開し、多発性血管炎薬とグローバル肉芽腫症市場の包括的な分析を提供します 、このレポートは、次のようにメーカーのデータをカバー:販売量、価格、収入、総利益、事業分布など、これらのデータは、消費者がより良い競争相手を知っているのに役立ちます。また、本レポートでは、世界のすべての地域と国をカバーし、市場規模、数量と金額、価格データなど、地域の発展状況を示しています。さらに、このレポートでは、次のようなセグメントデータもカバーしています:タイプ別、産業別、チャネル別などすべてのデータ期間は2015年から2021Eまでで、このレポートはまた2021年から2026年の予測データを提供します。

セクション1:100ドル--市場概要

セクション(2 3):1200米ドル--メーカー詳細
ビオノビスSA
ブリストル・マイヤーズ スクイブ社
ケモセントリックス株式会社
コヘルスバイオサイエンス株式会社
ジェノア・バイオファーマ株式会社
グラクソ・スミスクライン・ピーエルシー
イルトゥーファーマ
パナシアバイオテック株式会社
サンド・インターナショナルGmbH
国際バイオテクノロジーセンター(IBC) ジェネリウム

セクション4: 900ドル--地域別セグメンテーション
北米(米国、カナダ、メキシコ)
南米(ブラジル、アルゼンチン、その他)
アジア太平洋地域(中国、日本、インド、韓国、東南アジア)
欧州(ドイツ、イギリス、フランス、スペイン、イタリア)
中東・アフリカ(中近東、アフリカ)

セクション(5 6 7): 700米ドル--。
製品タイプ別セグメント
ベンラリズマブ
アバコパン
リツキシマブ・バイオシミラー

用途別セグメント
病院
クリニック

チャネル(直販、流通)別セグメンテーション

セクション8:500米ドル--市場予測(2021-2026年)

セクション9:600米ドル--川下顧客

第10節: 200米ドル--原材料と製造コスト

第11章:500ドル--結論

第12章:調査方法とデータソース



ページTOPに戻る


目次

Table of Contents
Section 1 Granulomatosis with Polyangiitis Drug Market Overview
1.1 Granulomatosis with Polyangiitis Drug Market Scope
1.2 COVID-19 Impact on Granulomatosis with Polyangiitis Drug Market
1.3 Global Granulomatosis with Polyangiitis Drug Market Status and Forecast Overview
1.3.1 Global Granulomatosis with Polyangiitis Drug Market Status 2016-2021
1.3.2 Global Granulomatosis with Polyangiitis Drug Market Forecast 2021-2026

Section 2 Global Granulomatosis with Polyangiitis Drug Market Manufacturer Share
2.1 Global Manufacturer Granulomatosis with Polyangiitis Drug Sales Volume
2.2 Global Manufacturer Granulomatosis with Polyangiitis Drug Business Revenue

Section 3 Manufacturer Granulomatosis with Polyangiitis Drug Business Introduction
3.1 Bionovis SA Granulomatosis with Polyangiitis Drug Business Introduction
3.1.1 Bionovis SA Granulomatosis with Polyangiitis Drug Sales Volume, Price, Revenue and Gross margin 2016-2021
3.1.2 Bionovis SA Granulomatosis with Polyangiitis Drug Business Distribution by Region
3.1.3 Bionovis SA Interview Record
3.1.4 Bionovis SA Granulomatosis with Polyangiitis Drug Business Profile
3.1.5 Bionovis SA Granulomatosis with Polyangiitis Drug Product Specification

3.2 Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Business Introduction
3.2.1 Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Sales Volume, Price, Revenue and Gross margin 2016-2021
3.2.2 Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Business Distribution by Region
3.2.3 Interview Record
3.2.4 Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Business Overview
3.2.5 Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Product Specification

3.3 Manufacturer three Granulomatosis with Polyangiitis Drug Business Introduction
3.3.1 Manufacturer three Granulomatosis with Polyangiitis Drug Sales Volume, Price, Revenue and Gross margin 2016-2021
3.3.2 Manufacturer three Granulomatosis with Polyangiitis Drug Business Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Granulomatosis with Polyangiitis Drug Business Overview
3.3.5 Manufacturer three Granulomatosis with Polyangiitis Drug Product Specification


Section 4 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Region)
4.1 North America Country
4.1.1 United States Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.1.2 Canada Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.1.3 Mexico Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.2.2 Argentina Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.3.2 Japan Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.3.3 India Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.3.4 Korea Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.3.5 Southeast Asia Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.4.2 UK Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.4.3 France Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.4.4 Spain Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.4.5 Italy Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
4.5.1 Africa Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.5.2 Middle East Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.6 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Region) Analysis

Section 5 Global Granulomatosis with Polyangiitis Drug Market Segmentation (by Product Type)
5.1 Product Introduction by Type
5.1.1 Benralizumab Product Introduction
5.1.2 Avacopan Product Introduction
5.1.3 Rituximab Biosimilar Product Introduction
5.2 Global Granulomatosis with Polyangiitis Drug Sales Volume by Avacopan016-2021
5.3 Global Granulomatosis with Polyangiitis Drug Market Size by Avacopan016-2021
5.4 Different Granulomatosis with Polyangiitis Drug Product Type Price 2016-2021
5.5 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Type) Analysis

Section 6 Global Granulomatosis with Polyangiitis Drug Market Segmentation (by Application)
6.1 Global Granulomatosis with Polyangiitis Drug Sales Volume by Application 2016-2021
6.2 Global Granulomatosis with Polyangiitis Drug Market Size by Application 2016-2021
6.2 Granulomatosis with Polyangiitis Drug Price in Different Application Field 2016-2021
6.3 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Application) Analysis

Section 7 Global Granulomatosis with Polyangiitis Drug Market Segmentation (by Channel)
7.1 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Analysis

Section 8 Granulomatosis with Polyangiitis Drug Market Forecast 2021-2026
8.1 Granulomatosis with Polyangiitis Drug Segmentation Market Forecast 2021-2026 (By Region)
8.2 Granulomatosis with Polyangiitis Drug Segmentation Market Forecast 2021-2026 (By Type)
8.3 Granulomatosis with Polyangiitis Drug Segmentation Market Forecast 2021-2026 (By Application)
8.4 Granulomatosis with Polyangiitis Drug Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Granulomatosis with Polyangiitis Drug Price Forecast

Section 9 Granulomatosis with Polyangiitis Drug Application and Client Analysis
9.1 Hospital Customers
9.2 Clinic Customers

Section 10 Granulomatosis with Polyangiitis Drug Manufacturing Cost of Analysis
11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview

Section 11 Conclusion

Section 12 Methodology and Data Source

Chart and Figure
Figure Granulomatosis with Polyangiitis Drug Product Picture
Chart Global Granulomatosis with Polyangiitis Drug Market Size (with or without the impact of COVID-19)
Chart Global Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Size (Million $) and Growth Rate 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Growth Rate 2021-2026
Chart Global Granulomatosis with Polyangiitis Drug Market Size (Million $) and Growth Rate 2021-2026
Chart 2016-2021 Global Manufacturer Granulomatosis with Polyangiitis Drug Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Granulomatosis with Polyangiitis Drug Sales Volume Share
Chart 2016-2021 Global Manufacturer Granulomatosis with Polyangiitis Drug Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Granulomatosis with Polyangiitis Drug Business Revenue Share
Chart Bionovis SA Granulomatosis with Polyangiitis Drug Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Bionovis SA Granulomatosis with Polyangiitis Drug Business Distribution
Chart Bionovis SA Interview Record (Partly)
Chart Bionovis SA Granulomatosis with Polyangiitis Drug Business Profile
Table Bionovis SA Granulomatosis with Polyangiitis Drug Product Specification
Chart Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Business Distribution
Chart Bristol-Myers Squibb Company Interview Record (Partly)
Chart Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Business Overview
Table Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Product Specification


Chart United States Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart United States Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Canada Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Canada Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Mexico Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Mexico Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Brazil Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Brazil Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Argentina Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Argentina Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart China Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart China Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Japan Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Japan Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart India Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart India Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Korea Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Korea Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Southeast Asia Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Germany Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Germany Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart UK Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart UK Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart France Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart France Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Spain Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Spain Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Italy Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Italy Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Africa Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Africa Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Middle East Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Middle East Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation Sales Volume (Units) by Region 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation Sales Volume (Units) Share by Region 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation Market size (Million $) by Region 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation Market size (Million $) Share by Region 2016-2021
Chart Benralizumab Product Figure
Chart Benralizumab Product Description
Chart Avacopan Product Figure
Chart Avacopan Product Description
Chart Rituximab Biosimilar Product Figure
Chart Rituximab Biosimilar Product Description
Chart Granulomatosis with Polyangiitis Drug Sales Volume (Units) by Avacopan016-2021
Chart Granulomatosis with Polyangiitis Drug Sales Volume (Units) Share by Type
Chart Granulomatosis with Polyangiitis Drug Market Size (Million $) by Avacopan016-2021
Chart Granulomatosis with Polyangiitis Drug Market Size (Million $) Share by Avacopan016-2021
Chart Different Granulomatosis with Polyangiitis Drug Product Type Price ($/Unit) 2016-2021
Chart Granulomatosis with Polyangiitis Drug Sales Volume (Units) by Application 2016-2021
Chart Granulomatosis with Polyangiitis Drug Sales Volume (Units) Share by Application
Chart Granulomatosis with Polyangiitis Drug Market Size (Million $) by Application 2016-2021
Chart Granulomatosis with Polyangiitis Drug Market Size (Million $) Share by Application 2016-2021
Chart Granulomatosis with Polyangiitis Drug Price in Different Application Field 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Sales Volume (Units) 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Share 2016-2021
Chart Granulomatosis with Polyangiitis Drug Segmentation Market Sales Volume (Units) Forecast (by Region) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Segmentation Market Sales Volume Forecast (By Region) Share 2021-2026
Chart Granulomatosis with Polyangiitis Drug Segmentation Market Size (Million USD) Forecast (By Region) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Segmentation Market Size Forecast (By Region) Share 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Type) Volume (Units) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Type) Volume (Units) Share 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Application) Market Size (Volume) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Application) Market Size (Volume) Share 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Application) Market Size (Value) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Application) Market Size (Value) Share 2021-2026
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Sales Volume (Units) 2021-2026
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Share 2021-2026
Chart Global Granulomatosis with Polyangiitis Drug Price Forecast 2021-2026
Chart Hospital Customers
Chart Clinic Customers


 

ページTOPに戻る


 

Summary

Global Granulomatosis with Polyangiitis Drug Market Status, Trends and COVID-19 Impact Report 2021
Single User License Report: 2350 USD
Corporate User License Report: 4700 USD
Section Price: As below

In the past few years, the Granulomatosis with Polyangiitis Drug market experienced a huge change under the influence of COVID-19, the global market size of Granulomatosis with Polyangiitis Drug reached (2021 Market size XXXX) million $ in 2021 from (2016 Market size XXXX) in 2016 with a CAGR of xxx from 2016-2021 is. As of now, the global COVID-19 Coronavirus Cases have exceeded 200 million, and the global epidemic has been basically under control, therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The World Bank predicts that the global economic output is expected to expand 4 percent in 2021 while 3.8 percent in 2022. According to our research on Granulomatosis with Polyangiitis Drug market and global economic environment, we forecast that the global market size of Granulomatosis with Polyangiitis Drug will reach (2026 Market size XXXX) million $ in 2026 with a CAGR of % from 2021-2026.

Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to recover and partially adapted to pandemic restrictions. The research and development of vaccines has made breakthrough progress, and many governments have also issued various policies to stimulate economic recovery, particularly in the United States, is likely to provide a strong boost to economic activity but prospects for sustainable growth vary widely between countries and sectors. Although the global economy is recovering from the great depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged period. The pandemic has exacerbated the risks associated with the decade-long wave of global debt accumulation. It is also likely to steepen the long-expected slowdown in potential growth over the next decade.

The world has entered the COVID-19 epidemic recovery period. In this complex economic environment, we published the Global Granulomatosis with Polyangiitis Drug Market Status, Trends and COVID-19 Impact Report 2021, which provides a comprehensive analysis of the global Granulomatosis with Polyangiitis Drug market , This Report covers the manufacturer data, including: sales volume, price, revenue, gross margin, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows the regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type wise, industry wise, channel wise etc. all the data period is from 2015-2021E, this report also provide forecast data from 2021-2026.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
Bionovis SA
Bristol-Myers Squibb Company
ChemoCentryx Inc
Coherus BioSciences Inc
Genor BioPharma Co Ltd
GlaxoSmithKline Plc
Iltoo Pharma
Panacea Biotec Ltd
Sandoz International GmbH
The International Biotechnology Center (IBC) Generium

Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)

Section (5 6 7): 700 USD——
Product Type Segmentation
Benralizumab
Avacopan
Rituximab Biosimilar

Application Segmentation
Hospital
Clinic

Channel (Direct Sales, Distribution Channel) Segmentation

Section 8: 500 USD——Market Forecast (2021-2026)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source



ページTOPに戻る


Table of Contents

Table of Contents
Section 1 Granulomatosis with Polyangiitis Drug Market Overview
1.1 Granulomatosis with Polyangiitis Drug Market Scope
1.2 COVID-19 Impact on Granulomatosis with Polyangiitis Drug Market
1.3 Global Granulomatosis with Polyangiitis Drug Market Status and Forecast Overview
1.3.1 Global Granulomatosis with Polyangiitis Drug Market Status 2016-2021
1.3.2 Global Granulomatosis with Polyangiitis Drug Market Forecast 2021-2026

Section 2 Global Granulomatosis with Polyangiitis Drug Market Manufacturer Share
2.1 Global Manufacturer Granulomatosis with Polyangiitis Drug Sales Volume
2.2 Global Manufacturer Granulomatosis with Polyangiitis Drug Business Revenue

Section 3 Manufacturer Granulomatosis with Polyangiitis Drug Business Introduction
3.1 Bionovis SA Granulomatosis with Polyangiitis Drug Business Introduction
3.1.1 Bionovis SA Granulomatosis with Polyangiitis Drug Sales Volume, Price, Revenue and Gross margin 2016-2021
3.1.2 Bionovis SA Granulomatosis with Polyangiitis Drug Business Distribution by Region
3.1.3 Bionovis SA Interview Record
3.1.4 Bionovis SA Granulomatosis with Polyangiitis Drug Business Profile
3.1.5 Bionovis SA Granulomatosis with Polyangiitis Drug Product Specification

3.2 Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Business Introduction
3.2.1 Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Sales Volume, Price, Revenue and Gross margin 2016-2021
3.2.2 Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Business Distribution by Region
3.2.3 Interview Record
3.2.4 Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Business Overview
3.2.5 Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Product Specification

3.3 Manufacturer three Granulomatosis with Polyangiitis Drug Business Introduction
3.3.1 Manufacturer three Granulomatosis with Polyangiitis Drug Sales Volume, Price, Revenue and Gross margin 2016-2021
3.3.2 Manufacturer three Granulomatosis with Polyangiitis Drug Business Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Granulomatosis with Polyangiitis Drug Business Overview
3.3.5 Manufacturer three Granulomatosis with Polyangiitis Drug Product Specification


Section 4 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Region)
4.1 North America Country
4.1.1 United States Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.1.2 Canada Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.1.3 Mexico Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.2.2 Argentina Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.3.2 Japan Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.3.3 India Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.3.4 Korea Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.3.5 Southeast Asia Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.4.2 UK Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.4.3 France Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.4.4 Spain Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.4.5 Italy Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
4.5.1 Africa Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.5.2 Middle East Granulomatosis with Polyangiitis Drug Market Size and Price Analysis 2016-2021
4.6 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Region) Analysis

Section 5 Global Granulomatosis with Polyangiitis Drug Market Segmentation (by Product Type)
5.1 Product Introduction by Type
5.1.1 Benralizumab Product Introduction
5.1.2 Avacopan Product Introduction
5.1.3 Rituximab Biosimilar Product Introduction
5.2 Global Granulomatosis with Polyangiitis Drug Sales Volume by Avacopan016-2021
5.3 Global Granulomatosis with Polyangiitis Drug Market Size by Avacopan016-2021
5.4 Different Granulomatosis with Polyangiitis Drug Product Type Price 2016-2021
5.5 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Type) Analysis

Section 6 Global Granulomatosis with Polyangiitis Drug Market Segmentation (by Application)
6.1 Global Granulomatosis with Polyangiitis Drug Sales Volume by Application 2016-2021
6.2 Global Granulomatosis with Polyangiitis Drug Market Size by Application 2016-2021
6.2 Granulomatosis with Polyangiitis Drug Price in Different Application Field 2016-2021
6.3 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Application) Analysis

Section 7 Global Granulomatosis with Polyangiitis Drug Market Segmentation (by Channel)
7.1 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Analysis

Section 8 Granulomatosis with Polyangiitis Drug Market Forecast 2021-2026
8.1 Granulomatosis with Polyangiitis Drug Segmentation Market Forecast 2021-2026 (By Region)
8.2 Granulomatosis with Polyangiitis Drug Segmentation Market Forecast 2021-2026 (By Type)
8.3 Granulomatosis with Polyangiitis Drug Segmentation Market Forecast 2021-2026 (By Application)
8.4 Granulomatosis with Polyangiitis Drug Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Granulomatosis with Polyangiitis Drug Price Forecast

Section 9 Granulomatosis with Polyangiitis Drug Application and Client Analysis
9.1 Hospital Customers
9.2 Clinic Customers

Section 10 Granulomatosis with Polyangiitis Drug Manufacturing Cost of Analysis
11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview

Section 11 Conclusion

Section 12 Methodology and Data Source

Chart and Figure
Figure Granulomatosis with Polyangiitis Drug Product Picture
Chart Global Granulomatosis with Polyangiitis Drug Market Size (with or without the impact of COVID-19)
Chart Global Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Size (Million $) and Growth Rate 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Growth Rate 2021-2026
Chart Global Granulomatosis with Polyangiitis Drug Market Size (Million $) and Growth Rate 2021-2026
Chart 2016-2021 Global Manufacturer Granulomatosis with Polyangiitis Drug Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Granulomatosis with Polyangiitis Drug Sales Volume Share
Chart 2016-2021 Global Manufacturer Granulomatosis with Polyangiitis Drug Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Granulomatosis with Polyangiitis Drug Business Revenue Share
Chart Bionovis SA Granulomatosis with Polyangiitis Drug Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Bionovis SA Granulomatosis with Polyangiitis Drug Business Distribution
Chart Bionovis SA Interview Record (Partly)
Chart Bionovis SA Granulomatosis with Polyangiitis Drug Business Profile
Table Bionovis SA Granulomatosis with Polyangiitis Drug Product Specification
Chart Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Business Distribution
Chart Bristol-Myers Squibb Company Interview Record (Partly)
Chart Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Business Overview
Table Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Product Specification


Chart United States Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart United States Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Canada Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Canada Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Mexico Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Mexico Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Brazil Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Brazil Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Argentina Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Argentina Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart China Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart China Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Japan Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Japan Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart India Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart India Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Korea Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Korea Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Southeast Asia Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Southeast Asia Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Germany Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Germany Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart UK Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart UK Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart France Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart France Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Spain Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Spain Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Italy Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Italy Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Africa Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Africa Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Middle East Granulomatosis with Polyangiitis Drug Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Middle East Granulomatosis with Polyangiitis Drug Sales Price (USD/Unit) 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation Sales Volume (Units) by Region 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation Sales Volume (Units) Share by Region 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation Market size (Million $) by Region 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation Market size (Million $) Share by Region 2016-2021
Chart Benralizumab Product Figure
Chart Benralizumab Product Description
Chart Avacopan Product Figure
Chart Avacopan Product Description
Chart Rituximab Biosimilar Product Figure
Chart Rituximab Biosimilar Product Description
Chart Granulomatosis with Polyangiitis Drug Sales Volume (Units) by Avacopan016-2021
Chart Granulomatosis with Polyangiitis Drug Sales Volume (Units) Share by Type
Chart Granulomatosis with Polyangiitis Drug Market Size (Million $) by Avacopan016-2021
Chart Granulomatosis with Polyangiitis Drug Market Size (Million $) Share by Avacopan016-2021
Chart Different Granulomatosis with Polyangiitis Drug Product Type Price ($/Unit) 2016-2021
Chart Granulomatosis with Polyangiitis Drug Sales Volume (Units) by Application 2016-2021
Chart Granulomatosis with Polyangiitis Drug Sales Volume (Units) Share by Application
Chart Granulomatosis with Polyangiitis Drug Market Size (Million $) by Application 2016-2021
Chart Granulomatosis with Polyangiitis Drug Market Size (Million $) Share by Application 2016-2021
Chart Granulomatosis with Polyangiitis Drug Price in Different Application Field 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Sales Volume (Units) 2016-2021
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Share 2016-2021
Chart Granulomatosis with Polyangiitis Drug Segmentation Market Sales Volume (Units) Forecast (by Region) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Segmentation Market Sales Volume Forecast (By Region) Share 2021-2026
Chart Granulomatosis with Polyangiitis Drug Segmentation Market Size (Million USD) Forecast (By Region) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Segmentation Market Size Forecast (By Region) Share 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Type) Volume (Units) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Type) Volume (Units) Share 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Application) Market Size (Volume) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Application) Market Size (Volume) Share 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Application) Market Size (Value) 2021-2026
Chart Granulomatosis with Polyangiitis Drug Market Segmentation (By Application) Market Size (Value) Share 2021-2026
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Sales Volume (Units) 2021-2026
Chart Global Granulomatosis with Polyangiitis Drug Market Segmentation (By Channel) Share 2021-2026
Chart Global Granulomatosis with Polyangiitis Drug Price Forecast 2021-2026
Chart Hospital Customers
Chart Clinic Customers


 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(drug)の最新刊レポート


よくあるご質問


BisReport Consulting Co., Ltd.社はどのような調査会社ですか?


BisReport Consultingは北米、欧州、中国、日本、インド、韓国、東南アジアなどの世界主要国/地域の企業に化学品、材料、自動車、機械、医薬品、医療機器などの市場情報を提供しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/08 10:26

154.13 円

166.76 円

202.76 円

ページTOPに戻る